Table 3.
Clinical outcomes of ICSI for the SLO3-mutated Man
| SLO3-mutated Man | OAT as Controls | |
|---|---|---|
| Male age (years) | 29 | 30.1 ± 4.9 |
| Female age (years) | 34 | 28.4 ± 4.2 |
| No. of ICSI cycles | 1 | 301 |
| No. of oocytes injected | 15 | 11 (1, 34) |
| Fertilization rate (%) (and number) | 100 (15/15) |
83.3 (12.5, 100.0) (3219/4077) |
| Cleavage rate (%) (and number) | 100 (15/15) |
100.0 (66.7, 100.0) (3188/3219) |
| 8-Cell formation rate (%) (and number) | 73 (11/15) | 70.6 (10.5, 100.0) |
| Blastocyst formation rate (%) (and number) | 73 (11/15) | 60.0 (0, 100.0) |
| No. of transfer cycles | 1 | 301 |
| Number of embryos transferred per cycle | 2 | 2 (1, 2) |
| Implantation rate (%) | 50 | 47.9 (229/478) |
| Clinical pregnancy rate (%) | 100 | 57.1 (172/301) |
| Miscarriage rate (%) | 0 | 11.6 (20/172) |
OAT Oligoasthenoteratozoospermia; The number of OAT couples is 301